Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Genes, Chromosomes & Cancer|November 7, 2024
Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)Anders Östlund, Ahmed Waraky, Anna Staffas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual DiseaseAnne Tierens, Nira Arad-Cohen, Daniel Cheuk, et al.
British Journal of Haematology|December 31, 2019
Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood LeukemiaSarah Elitzur, Nira Arad-Cohen, Assaf Barg, et al.
Expert Review of Anticancer Therapy|October 3, 2022
Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortiumNira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, et al.
British Journal of Haematology|August 19, 2025
Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML studyMorten Krogh Herlin, Eigil Kjeldsen, Jonas Abrahamsson, et al.
Haematologica|May 9, 2024
Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocolBernward Zeller, Nira Arad-Cohen, Daniel Cheuk, et al.
Pediatric Blood & Cancer|July 27, 2026
Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First RelapseCamilla Poulsen, Kristian Juul Sandahl, Lene Karlsson, et al.
Blood|August 29, 2018
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study GroupSanne Noort, Martin Zimmermann, Dirk Reinhardt, et al.
Blood Advances|February 3, 2023
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndromeNikhil Raghuram, Daisuke Hasegawa, Kentaro Nakashima, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Pageof 4